Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease
Gopichand Gutti, Kakarla Ramakrishna, Devendra Kumar, et al.
European Journal of Medicinal Chemistry (2019) Vol. 182, pp. 111613-111613
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

WNT-β Catenin Signaling as a Potential Therapeutic Target for Neurodegenerative Diseases: Current Status and Future Perspective
Kakarla Ramakrishna, Lakshmi Vineela Nalla, Naresh Dumala, et al.
Diseases (2023) Vol. 11, Iss. 3, pp. 89-89
Open Access | Times Cited: 96
Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress
Zhipei Sang, Keren Wang, Jianghong Dong, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114464-114464
Closed Access | Times Cited: 86
Indole-3 Carbinol and Diindolylmethane Mitigated β-Amyloid-Induced Neurotoxicity and Acetylcholinesterase Enzyme Activity: In Silico, In Vitro, and Network Pharmacology Study
Kakarla Ramakrishna, Praditha Karuturi, Queen Siakabinga, et al.
Diseases (2024) Vol. 12, Iss. 8, pp. 184-184
Open Access | Times Cited: 28
Indole 3 carbinol attenuated memory impairment, oxidative stress, inflammation, and apoptosis in bilateral common carotid artery occlusion induced brain damage in rats
Srikanth Yalabaka, T. Julius, Miriyala Sai Siva Gayathri, et al.
3 Biotech (2025) Vol. 15, Iss. 2
Closed Access | Times Cited: 2
Preclinical Models for Alzheimer’s Disease: Past, Present, and Future Approaches
Ansab Akhtar, Shraddha Manish Gupta, Shubham Dwivedi, et al.
ACS Omega (2022) Vol. 7, Iss. 51, pp. 47504-47517
Open Access | Times Cited: 41
Development of multifunctional fluorescence-emitting potential theranostic agents for Alzheimer’s disease
Nilesh Gajanan Bajad, Gajendra T.A., Mansi Kothari, et al.
Talanta (2025) Vol. 287, pp. 127574-127574
Closed Access | Times Cited: 1
Discovery of pyrazoline analogs as multi-targeting cholinesterase, β-secretase and Aβ aggregation inhibitors through lead optimization strategy
Nilesh Gajanan Bajad, Jatin Jangra, T A Gajendra, et al.
International Journal of Biological Macromolecules (2025), pp. 140436-140436
Closed Access | Times Cited: 1
Discovery of multi-target directed 3-OH pyrrolidine derivatives through a semisynthetic approach from alkaloid vasicine for the treatment of Alzheimer's disease
Kancharla Bhanukiran, Gajendra T.A., Sairam Krishnamurthy, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115145-115145
Closed Access | Times Cited: 22
Vasicinone, a pyrroloquinazoline alkaloid from Adhatoda vasica Nees enhances memory and cognition by inhibiting cholinesterases in Alzheimer's disease
Kancharla Bhanukiran, Ravi Singh, T A Gajendra, et al.
Phytomedicine Plus (2023) Vol. 3, Iss. 2, pp. 100439-100439
Open Access | Times Cited: 20
Enhancing the Therapeutic Effect in Alzheimer's Disease Drugs: The role of Polypharmacology and Cholinesterase inhibitors
M. Margarida Martins, Paula S. Branco, Luı́sa M. Ferreira
ChemistrySelect (2023) Vol. 8, Iss. 10
Open Access | Times Cited: 18
Discovery of triazole-bridged aryl adamantane analogs as an intriguing class of multifunctional agents for treatment of Alzheimer's disease
Gopichand Gutti, Jennifer Leifeld, Kakarla Ramakrishna, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115670-115670
Closed Access | Times Cited: 18
Development of multi-targetable chalcone derivatives bearing N-aryl piperazine moiety for the treatment of Alzheimer's disease
Nilesh Gajanan Bajad, Ravi Bhushan Singh, Gajendra T.A., et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107082-107082
Closed Access | Times Cited: 6
Benzimidazole and Benzoxazole Derivatives Against Alzheimer's Disease
Nagihan Faydalı, Özlem Temiz‐Arpacı
Chemistry & Biodiversity (2024) Vol. 21, Iss. 6
Closed Access | Times Cited: 6
Evaluation of Activity of Some 2,5-Disubstituted Benzoxazole Derivatives against Acetylcholinesterase, Butyrylcholinesterase and Tyrosinase: ADME Prediction, DFT and Comparative Molecular Docking Studies
İsmail Çeli̇k, Meryem Erol, Özlem Temiz‐Arpacı, et al.
Polycyclic aromatic compounds (2020) Vol. 42, Iss. 2, pp. 412-423
Closed Access | Times Cited: 40
Development and Evaluation of Some Molecular Hybrids of N-(1-Benzylpiperidin-4-yl)-2-((5-phenyl-1,3,4-oxadiazol-2-yl)thio) as Multifunctional Agents to Combat Alzheimer’s Disease
Digambar Kumar Waiker, Akash Verma, Poorvi Saraf, et al.
ACS Omega (2023) Vol. 8, Iss. 10, pp. 9394-9414
Open Access | Times Cited: 13
Morin attenuated the global cerebral ischemia via antioxidant, anti-inflammatory, and antiapoptotic mechanisms in rats
Narayanarao Alla, Sujatha Palatheeya, Siva Reddy Challa, et al.
Metabolic Brain Disease (2024) Vol. 39, Iss. 7, pp. 1323-1334
Closed Access | Times Cited: 5
Structure-based screening and molecular dynamics simulation studies for the identification of potential acetylcholinesterase inhibitors
Ankit Ganeshpurkar, Ravi Singh, Pravin Gore, et al.
Molecular Simulation (2019) Vol. 46, Iss. 3, pp. 169-185
Open Access | Times Cited: 37
Neuroprotective effects of quercetin produced by an endophytic fungus Nigrospora oryzae isolated from Tinospora cordifolia
Rajat Vig, Fatima Bhadra, Sukesh Kumar Gupta, et al.
Journal of Applied Microbiology (2021) Vol. 132, Iss. 1, pp. 365-380
Closed Access | Times Cited: 29
Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer's disease
Tongtong Liu, Shiming Chen, Jiyu Du, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113973-113973
Closed Access | Times Cited: 29
Promising heterocycle-based scaffolds in recent (2019–2021) anti-Alzheimer's drug design and discovery
Atukuri Dorababu
European Journal of Pharmacology (2022) Vol. 920, pp. 174847-174847
Closed Access | Times Cited: 22
Advanced Biomaterials in Neuroprotection: Innovations and Clinical Applications
Kakarla Ramakrishna, Matte Kasi Viswanadh, Naresh Dumala, et al.
(2025), pp. 69-92
Closed Access
Development of Donor–Acceptor Architecture-Based Potential Theranostic Fluorescent Probes for Alzheimer’s Disease
Nilesh Gajanan Bajad, Gajendra T.A., Khushboo Sharma, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Indene-Derived Hydrazides Targeting Acetylcholinesterase Enzyme in Alzheimer’s: Design, Synthesis, and Biological Evaluation
Shraddha Manish Gupta, Ashok Behera, Neetesh Kumar Jain, et al.
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 94-94
Open Access | Times Cited: 16
Tangeretin confers neuroprotection, cognitive and memory enhancement in global cerebral ischemia in rats
Narayanarao Alla, Sujatha Palatheeya, Siva Reddy Challa, et al.
3 Biotech (2023) Vol. 14, Iss. 1
Closed Access | Times Cited: 9
Design, synthesis, and biological evaluation of aromatic tertiary amine derivatives as selective butyrylcholinesterase inhibitors for the treatment of Alzheimer's disease
Xin Lü, Nan Qin, Yijun Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114729-114729
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top